Company / Operating Income per Share
enGene Holdings Inc. Operating Income per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.41
FY2025
5-year range
-$37.63 / -$1.65
FY2022-FY2025
Trend
-46.1%
vs FY2024
Sector context
#125 of 196
Health Care
What the data says
At $-2.41, enGene Holdings Inc.'s operating income per share ranks #125 of 196 in the Health Care sector. Improved from $-37.63 to $-2.41 over the past 2 years.
Based on SEC 10-K filings.
-2.41 in FY2025.
Improved from $-37.63 to $-2.41 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#125 of 196 in Health CareTop 64% of 196This company -$2.41 Sector average -$46.00
▼
+94.8% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 46.1% year-over-year.
- Ranks #125 out of 196 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.41 | -46.1% |
| FY2024 | -$1.65 | +95.6% |
| FY2023 | -$37.63 | -26.9% |
| FY2022 | -$29.65 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026